The influence of bacille Calmette-Guérin vaccine strain on the immune response against tuberculosis: A randomized trial

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 2, 2012, Pages 213-222

  Ritz, Nicole ^a,b,c   Dutta, Binita ^b   Donath, Susan ^a,b   Casalaz, Dan ^d   Connell, Tom G ^a,b,c   Tebruegge, Marc ^a,b   Robins Browne, Roy ^a,b   Hanekom, Willem A ^e   Britton, Warwick J ^f   Curtis, Nigel ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d MERCY HOSPITAL FOR WOMEN   (Australia)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

BCG; Immune response; Protection; Tuberculosis; Vaccine strain

Indexed keywords

BCG VACCINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2;

ARTICLE; BACTERIAL STRAIN; BCG VACCINATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENMARK; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; JAPAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RUSSIAN FEDERATION; TH1 CELL; TUBERCULOSIS;

ALGORITHMS; AUSTRALIA; BCG VACCINE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENMARK; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HOSPITALS, MATERNITY; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; PRACTICE GUIDELINES AS TOPIC; RUSSIA; SAMPLING STUDIES; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINATION;

EID: 84856000776     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201104-0714OC     Document Type: Article

References (43)

1. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999;284:1520-1523.
2. Ritz N, Curtis N. Mapping the global use of different BCG vaccine strains. Tuberculosis (Edinb) 2009;89:248-251.
3. Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N. Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev 2008;32:821-841.
4. Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. JAMA 2004;291:2086-2091. (Pubitemid 38580151)
5. Chan SL, Allen G, Pio A. Comparison of the efficacy of two strains of BCG vaccine for prevention of tuberculosis among newborn children in Hong Kong. Bull Int Union Tuberc 1966;61:36-37.
6. Tuberculosis Research Centre (ICMR) C. Fifteen year follow up of trial of BCG vaccines in South India for tuberculosis prevention. Indian J Med Res 1999;110:56-69.
7. Hoft DF, Kemp EB, Marinaro M, Cruz O, Kiyono H, McGhee JR, Belisle JT, Milligan TW, Miller JP, Belshe RB. A double-blind, placebo-controlled study of mycobacterium-specific human immune responses induced by intradermal Bacille Calmette-Guerin vaccination. J Lab Clin Med 1999;134:244-252. (Pubitemid 29423097)
8. Gorak-Stolinska P, Weir RE, Floyd S, Lalor MK, Stenson S, Branson K, Blitz R, Luke S, Nazareth B, Ben-Smith A. Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: comparison with Glaxo-Evans 1077 BCG vaccine. Vaccine 2006;24:5726-5733. (Pubitemid 43949426)
9. Davids V, Hanekom WA, Mansoor N, Gamieldien H, Gelderbloem SJ, Hawkridge A, Hussey GD, Hughes EJ, Soler J, Murray RA, et al. The effect of Bacille Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis 2006;193:531-536. (Pubitemid 43202744)
10. Hussey GD, Watkins MLV, Goddard EA, Gottschalk S, Hughes EJ, Iloni K, Kibel MA, Ress SR. Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology 2002;105:314-324. (Pubitemid 34304408)
11. Vijayalakshmi V, Murthy KJ, Kumar S, Kiran AL. Comparison of the immune responses in children vaccinated with three strains of BCG vaccine. Indian Pediatr 1995;32:979-982.
12. Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet 2010;375:2110-2119.
13. Ritz N, Dutta B, Donath S, Tebruegge M, Connell T, Robins-Browne R, Britton WJ, Hanekom WA, Curtis N. The influence of Mycobacterium bovis Bacille Calmette-Guérin vaccine strain on the immune response and protection against tuberculosis. Presented at the Annual Meeting of the European Society of Paediatric Infectious Diseases. May 2010, Nice, France; 2010.
14. Australian Technical Advisory Group on Immunisation. Tuberculosis. In: Australian immunisation handbook, 9 ed. Australia: Australian Government Department of Health and Ageing. 2008. pp. 297-302.
15. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, Koup RA. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281:65-78. (Pubitemid 37324571)
16. Cohen J. Statistical power analysis for the behavioural sciences. Mahwah, NJ: Lawrence Earlbaum Associates; 1988.
17. Wilkinson KA, Wilkinson RJ. Polyfunctional T cells in human tuberculosis. Eur J Immunol 2010;40:2139-2142.
18. Tchilian EZ, Desel C, Forbes EK, Bandermann S, Sander CR, Hill AV, McShane H, Kaufmann SH. Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)urec hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85a against murine tuberculosis. Infect Immun 2009;77:622-631.
19. Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, Rosenkrands I, Andersen P. Tuberculosis subunit vaccination provides long-termprotective immunity characterized by multifunctional CD4 memory T cells. J Immunol 2009;182:8047-8055.
20. Aagaard C, Hoang TT, Izzo A, Billeskov R, Troudt J, Arnett K, Keyser A, Elvang T, Andersen P, Dietrich J. Protection and polyfunctional T cells induced by AG85b-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS ONE 2009;4:e5930.
21. Forbes EK, Sander C, Ronan EO, McShane H, Hill AV, Beverley PC, Tchilian EZ. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against mycobacterium tuberculosis aerosol challenge in mice. J Immunol 2008; 181:4955-4964.
22. Sutherland JS, Young JM, Peterson KL, Sanneh B, Whittle HC, Rowland-Jones SL, Adegbola RA, Jaye A, Ota MO. Polyfunctional CD4+ and CD8+ T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment. J Immunol 2010; 184:6537-6544.
23. Day CL, Mkhwanazi N, Reddy S, Mncube Z, van der Stok M, Klenerman P, Walker BD. Detection of polyfunctional mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J Infect Dis 2008;197:990-999. (Pubitemid 351590027)
24. Kalsdorf B, Scriba TJ, Wood K, Day CL, Dheda K, Dawson R, Hanekom WA, Lange C, Wilkinson RJ. HIV-1 infection impairs the bronchoalveolar T cell response to mycobacteria. Am J Respir Crit Care Med 2009;180:1262-1270.
25. Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, Dosanjh DP, Guyot-Revol V, Gunatheesan R, Klenerman P, Lalvani A. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007;178:5217-5226. (Pubitemid 46595306)
26. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, Titone L, Galati D, Bocchino M, Matarese A, Salerno A, et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010;40:2211-2220.
27. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 2009;39:723-729.
28. Kagina BM, Abel B, Scriba TJ, Hughes EJ, Keyser A, Soares A, Gamieldien H, Sidibana M, Hatherill M, Gelderbloem S, et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis, following BCG vaccination of newborns. Am J Respir Crit Care Med 2010;182:1073-1079.
29. Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, Nicod LP, Cavassini M, Calandra T, Blanchet CL, Jaton K, et al. Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 2011;17:372-376.
30. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, et al. Multifunctional Th1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007;13:843-850. (Pubitemid 47038186)
31. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008;8:247-258. (Pubitemid 351432801)
32. Cooper AM, D'Souza C, Frank AA, Orme IM. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect Immun 1997;65:1317-1320. (Pubitemid 27146619)
33. Smith SM, Malin AS, Pauline T, Lukey, Atkinson SE, Content J, Huygen K, Dockrell HM. Characterization of human Mycobacterium bovis Bacille Calmette-Guerin-reactive CD8+ T cells. Infect Immun 1999;67:5223-5230. (Pubitemid 29455295)
34. Grotzke JE, Lewinsohn DM. Role of CD8+ T lymphocytes in control of Mycobacterium tuberculosis infection. Microbes Infect 2005;7:776-788.
35. van de Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R. Cytotoxic human CD4(+) T cells. Curr Opin Immunol 2008;20:339-343.
36. Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and fas/fas ligand-independent mechanism. J Immunol 2001;167:2734-2742. (Pubitemid 32768904)
37. Fazal BA, Telzak EE, Blum S, Pollard CL, Bar M, Ernst JA, Turett GS. Impact of a coordinated tuberculosis team in an inner-city hospital in New York City. Infect Control Hosp Epidemiol 1995;16: 340-343.
38. Pithie AD, Lammas DA, Fazal N, Rahelu M, Bartlett R, Gaston JS, Kumararatne DS. CD4+ cytolytic T cells can destroy autologous and MHC-matched macrophages but fail to kill intracellular Mycobacterium bovis-BCG. FEMS Immunol Med Microbiol 1995;11:145-154.
39. Murray RA, Mansoor N, Harbacheuski R, Soler J, Davids V, Soares A, Hawkridge A, Hussey GD, Maecker H, Kaplan G, et al. Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response. J Immunol 2006;177: 5647-5651. (Pubitemid 44527640)
40. Capinos Scherer CF, Endsley JJ, de Aguiar JB, Jacobs WR Jr, Larsen MH, Palmer MV, Nonnecke BJ, Ray Waters W, Mark Estes D. Evaluation of granulysin and perforin as candidate biomarkers for protection following vaccination with Mycobacterium bovis BCG or M. bovis delta RD1. Transbound Emerg Dis 2009;56:228-239.
41. Sahiratmadja E, Alisjahbana B, Buccheri S, Di Liberto D, de Boer T, Adnan I, van Crevel R, Klein MR, van Meijgaarden KE, Nelwan RH, et al. Plasma granulysin levels and cellular interferon-gamma production correlate with curative host responses in tuberculosis, while plasma interferon-gamma levels correlate with tuberculosis disease activity in adults. Tuberculosis (Edinb) 2007;87:312-321. (Pubitemid 46936241)
42. Holt EA, Moulton LH, Siberry GK, Halsey NA. Differential mortality by measles vaccine titer and sex. J Infect Dis 1993;168:1087-1096. (Pubitemid 23317120)
43. Nagayama Y, Tsubaki T, Sawada K, Taguchi K, Nakayama S, Toba T. Age and sex as factors of response to RSV infections among those with previous history of wheezing. Pediatr Allergy Immunol 2006;17: 376-381. (Pubitemid 43989961)